Goa Medical College sees alarming numbers of chronic liver disease admissions and deaths, with an increase in younger ...

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...

Cirrhosis is a condition in which scar tissue gradually replaces your healthy liver cells. It usually happens over a long period, often due to hepatitis, alcohol use disorder, or metabolic ...

Goa is witnessing a worrying trend of rising alcohol-related health issues, with over 300 deaths annually due to liver ...

Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030 Ramat Gan, Israel, Feb.

USA: A recent study highlights the potential benefits of metabolic surgery in improving liver outcomes among patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

Some of the most telling signs of a cardiac event taking place include pain, tightness or heaviness of the chest; unusual ...

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.